Rethinking Immunotherapy Drug Development in Head and Neck Squamous Cell Carcinoma: The Role of Biologic Context and Treatment Sequencing

Onco · Published 2026-07-31 · DOI 10.3390/onco6030037

Free full text

Authors (11)

Sameeha Sajid, Muhammad Daud Abdullah, Aishwarya Hanspal, Daniel Thomas Jones, Rishi Kumar Nanda, Ramaditya Srinivasmurthy, Jason Ta, Abbas Ali Hussain, Riccesha Hattin, Hatim Gemil, Kyaw Zin Thein

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Sajid, S., Abdullah, M., Hanspal, A., et al. (2026). Rethinking Immunotherapy Drug Development in Head and Neck Squamous Cell Carcinoma: The Role of Biologic Context and Treatment Sequencing. Onco. https://doi.org/10.3390/onco6030037

Related articles